Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 1;6(2):e2254298.
doi: 10.1001/jamanetworkopen.2022.54298.

Incidence of Chronic Spontaneous Urticaria Following Receipt of the COVID-19 Vaccine Booster in Switzerland

Olivier Duperrex  1 , Francesco Tommasini  2 , Yannick D Muller  2
Affiliations

Incidence of Chronic Spontaneous Urticaria Following Receipt of the COVID-19 Vaccine Booster in Switzerland

Olivier Duperrex et al. JAMA Netw Open. .

Erratum in

  • Error in Table 1 and Results.
    [No authors listed] [No authors listed] JAMA Netw Open. 2023 Apr 3;6(4):e239463. doi: 10.1001/jamanetworkopen.2023.9463. JAMA Netw Open. 2023. PMID: 37017977 Free PMC article. No abstract available.
No abstract available

Plain language summary

This cohort study examines the association of the COVID-19 vaccine booster with chronic spontaneous urticaria in Swiss patients.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Similar articles

See all similar articles

Cited by

References

    1. Federal Office for Public Health . COVID-19 Switzerland Dashboard. Accessed August 29, 2022. https://www.covid19.admin.ch/en/vaccination/persons
    1. Zuberbier T, Abdul Latiff AH, Abuzakouk M, et al. . The international EAACI/GA2LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2022;77(3):734-766. doi:10.1111/all.15090 - DOI - PubMed
    1. Pescosolido E, Muller YD, Sabaté-Brescó M, et al. . Clinical and immunological data from chronic urticaria onset after mRNA SARS-CoV-2 vaccines. Clin Exp Allergy. 2022;52(11):1343-1346. doi:10.1111/cea.14214 - DOI - PMC - PubMed
    1. Stehlin F, Mahdi-Aljedani R, Canton L, et al. . Intradermal testing with COVID-19 mRNA vaccines predicts tolerance. Front Allergy. 2022;3:818049. doi:10.3389/falgy.2022.818049 - DOI - PMC - PubMed
    1. Obeid M, Suffiotti M, Pellaton C, et al. . Humoral responses against variants of concern by COVID-19 mRNA vaccines in immunocompromised patients. JAMA Oncol. 2022;8(5):e220446. doi:10.1001/jamaoncol.2022.0446 - DOI - PMC - PubMed

Supplementary concepts